Kolexia
Narjoz-Lucas Celine Pharmacien
Narjoz-Lucas Celine
Pharmacien
Hôpital Européen Georges Pompidou
Paris, France
58 Activités
44 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Déficit en dihydropyrimidine déshydrogénase Tumeurs colorectales héréditaires sans polypose Instabilité des microsatellites Tumeurs de l'endomètre Effets secondaires indésirables des médicaments Prédisposition génétique à une maladie Déficit en alpha-1-antitrypsine Glomérulonéphrite lupique Carcinome pulmonaire à petites cellules

Collaborateurs

Voir plus
Loriot Marie-Anne
Loriot Marie-Anne
Hôpital Européen Georges Pompidou, Paris, France
Blanchet Benoit
Blanchet Benoit
Hôpital Cochin, Paris, France
Goldwasser Francois
Goldwasser Francois
Hôpital Cochin, Paris, France
Thomas-Schoemann Audrey
Thomas-Schoemann Audrey
Hôpital Cochin, Paris, France

Industries

Voir plus
LFB
2 collaboration(s)
Dernière en 2021
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Plasma lipidomic analysis to investigate putative biomarkers of P-glycoprotein activity in healthy volunteers.
Clinical and translational science   02 août 2023
#3155 APOL1 GENOTYPE IS A MAJOR DETERMINANT OF LUPUS NEPHRITIS SEVERITY IN PATIENTS OF AFRICAN ANCESTRY
60th ERA Congress, 15-18 June 2023: Congress Abstracts   14 juin 2023
Hydroxychloroquine sulfate: A novel treatment for lipin-1 deficiency?
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie   05 mai 2023
Screening for dihydropyrimidine dehydrogenase deficiency by measuring uracilemia in chronic kidney disease patients is associated with a high rate of false positives.
Clinica chimica acta; international journal of clinical chemistry   01 avril 2023
Current diagnostic and clinical issues of screening for dihydropyrimidine dehydrogenase deficiency.
European journal of cancer (Oxford, England : 1990)   09 décembre 2022
Quantitative impact of pre-analytical process on plasma uracil when testing for dihydropyrimidine dehydrogenase deficiency.
British journal of clinical pharmacology   03 octobre 2022
Exposure-Response Analysis of Osimertinib in Patients with Advanced Non-Small-Cell Lung Cancer.
Pharmaceutics   01 septembre 2022
Imbalance between alpha-1-antitrypsin and interleukin 6 is associated with in-hospital mortality and thrombosis during COVID-19.
Biochimie   08 août 2022
Pretherapeutic screening for Dihydropyrimidine deshydrogenase deficiency in measuring uracilemia in dialysis patients leads to a high rate of falsely positive results.
Cancer chemotherapy and pharmacology   13 septembre 2021
Artificial increase of uracilemia during fluoropyrimidine treatment can lead to DPD deficiency misinterpretation.
Annals of oncology : official journal of the European Society for Medical Oncology   01 mars 2021